ImmunityBio Stock (NASDAQ: IBRX) stock price, news, charts, stock research, profile.
Open | $4.26 |
Close | $4.25 |
Volume / Avg. | 1.93M / 3.26M |
Day Range | $4.18 - $4.36 |
52 Wk Range | 1.25 - 10.53 |
Market Cap | $2.96B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 28.99% |
Days to Cover | 19.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ImmunityBio (NASDAQ:IBRX) through any online brokerage.
Other companies in ImmunityBio’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and TG Therapeutics (NASDAQ:TGTX).
ImmunityBio has a consensus price target of $6.38.
The stock price for ImmunityBio (NASDAQ: IBRX) is $4.25 last updated August 23, 2024 at 7:07 PM EDT.
There are no upcoming dividends for ImmunityBio.
ImmunityBio’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for ImmunityBio.
ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.